Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older
- People who have been diagnosed with breast cancer that has spread to other parts of the body, confirmed through a tissue sample test
- People who are menopausal, or whose ovaries have been medically suppressed (for example, through medication)
- People currently taking capivasertib (2 tablets twice daily, 4 days per week)
- People who have been on their current capivasertib dose without changes for at least 2 weeks
- People with a functional ability rating of 0 or 1 on a standard medical scale, meaning fully active or able to carry out light activity (confirm with trial site)
- People with a Body Mass Index (BMI) of 25 or above
- People who are able to give their informed agreement to take part in the study
- People who are willing to follow the study requirements, including wearing a continuous glucose monitor, tracking food intake through a mobile app, and making changes to their diet
- People who have access to a smartphone or tablet to use the study's mobile application
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with Type 1 diabetes
- People with Type 2 diabetes that is not well controlled (based on a specific blood sugar marker being above a certain level)
- People with a history of severe low blood sugar episodes
- People with eating disorders, or for whom fasting would be medically inadvisable
- People who are pregnant or breastfeeding
- People with significant digestive or gut conditions that affect how food is absorbed
- People who are unable to fast for medical reasons
- People who are already taking part in another study involving dietary changes
- People who have had significantly abnormal blood test results within 4 weeks before agreeing to join, such as low red blood cell levels, low platelet counts, abnormal liver function, or reduced kidney function (confirm specific thresholds with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of plasma from fasting in patients on PI3K inhibitors on cell viability; mechanisms by which fasting might enhance PI3K inhibitor efficacy through complementary molecular and cellular studies; Identify biomarkers/patient characteristics predicting the enhancement of PI3K inhibitor efficacy with fasting.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.